Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1214 results about "Dextran" patented technology

Dextran is a complex branched glucan (polysaccharide derived from the condensation of glucose). IUPAC defines dextrans as "Branched poly-α-d-glucosides of microbial origin having glycosidic bonds predominantly C-1 → C-6". Dextran chains are of varying lengths (from 3 to 2000 kilodaltons).

Probiotic microcapsule with function of improving intestinal microecology and key technology

The invention relates to the technical field of biological pharmacy, and discloses a probiotic microcapsule with a function of improving intestinal microecology, which comprises the following components in percentage by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU of lactobacillus rhamnosus; lactobacillus acidophilus: each gram of the formula contains 109 CFU; clostridium butyricum: each gram of the formula contains 108 CFU; 5%-8% of a nano sodium alginate-chitosan compound; 3%-5% of peptide nanoparticles; 2%-4% of a natural polymer intelligent response film; 3%-6% of arabinoxylan oligosaccharide; 4%-7% of resistant dextran; 2%-4% of lentinan; and 0.1%-0.3% of resveratrol. Through a double-layer or three-layer embedding technology of the nano sodium alginate-chitosan compound and the intelligent response polymer film, the tolerance of the probiotics in gastric acid and cholate environments is remarkably enhanced, and targeted release of the probiotics in small intestines and colon is ensured.
Owner:HENAN BUSINESS SCI RES INST

Application of OpgG and mutant thereof in production of human milk oligosaccharide

The invention belongs to the technical field of gene engineering, and particularly relates to applications of OpgG and a mutant thereof in production of human milk oligosaccharide. The invention provides a dextran biosynthetic protein OpgG mutant, and the OpgG mutant is obtained by mutating the 443rd amino acid from threonine to proline on the basis of a wild type dextran biosynthetic protein OpgG as shown in SEQ ID NO.1. The invention also provides a preparation method of the dextran biosynthetic protein OpgG mutant. An opgG gene and / or a T443P mutant coding gene are / is introduced into a human milk oligosaccharide production strain and applied to production of human milk oligosaccharide, and the yield of 3 '-SL, 6'-SL, LNT II, LNnT and LNT is greatly increased.
Owner:TIANJIN UNIV OF SCI & TECH

Multifunctional hydrogel and application thereof

The invention discloses multifunctional hydrogel and application thereof, and belongs to the technical field of biological medicine. According to the multifunctional hydrogel, ketal mercaptan with two hydrazide ends and oxidized dextran are cross-linked to form a cross-linked network containing dynamic covalent bonds. The preparation method comprises the following steps: dissolving ketal mercaptan with two hydrazide ends in deionized water to obtain a ketal mercaptan solution, dissolving oxidized dextran in deionized water to obtain an oxidized dextran solution, mixing the ketal mercaptan solution with the oxidized dextran solution, and standing to obtain the multifunctional hydrogel. The multifunctional hydrogel has pH / ROS dual responsiveness, can respond to inflammation microenvironment and low pH of infectious wounds, remove active oxygen, release therapeutic drugs, regulate macrophage polarization and relieve bacterial infection, thereby playing a key role in inflammation, proliferation and remodeling stages of wound healing to accelerate wound healing. The curcumin-encapsulated liposome is added into the multifunctional hydrogel, so that the antibacterial effect can be further improved.
Owner:WEIFANG MEDICAL UNIV

Composite hydrogel dressing for promoting wound healing, preparation and application

The invention relates to a composite hydrogel dressing for promoting wound healing as well as preparation and application thereof, and belongs to the technical field of biological medicines. The hydrogel disclosed by the invention is prepared by mixing gelatin, oxidized dextran and metal ion modified metal-organic framework compounds (MOF-Ag and MOF-Cu). In the mixed solution, amino groups in the gelatin and aldehyde groups of the oxidized dextran are subjected to a Schiff base cross-linking reaction, and the composite hydrogel is formed after standing. The loaded MOF-Ag has antibacterial and anti-biofilm effects on staphylococcus aureus and escherichia coli, and the loaded MOF-Cu has similar superoxide dismutase activity and similar glutathione peroxidase activity, so that excessive active oxygen can be removed, and inflammatory response can be relieved. The obtained hydrogel has good biocompatibility, proper mechanical properties and biological adhesion, stable rheological properties, excellent antibacterial and anti-inflammatory functions and a certain hemostatic function.
Owner:HUAZHONG UNIV OF SCI & TECH

Double-layer hydrogel for wound repair and infection monitoring as well as preparation method and application of double-layer hydrogel

The invention discloses double-layer hydrogel for wound repair and infection monitoring as well as a preparation method and application of the double-layer hydrogel, and belongs to the technical field of biological medicines. The preparation method comprises the following steps: (1) firstly, preparing an aldehyde dextran-mulberry extract solution; (2) preparing a chitosan quaternary ammonium salt-mulberry extract solution; (3) mixing and dissolving sodium alginate, aldehyde dextran and mulberry extract in a PBS (Phosphate Buffer Solution), so as to obtain an upper-layer hydrogel pre-polymerization solution; (4) mixing the aldehyde dextran-mulberry extract solution with the chitosan quaternary ammonium salt-mulberry extract solution, so as to prepare a lower layer hydrogel; and (5) adding the upper-layer hydrogel prepolymerization liquid above the lower-layer hydrogel, and spraying a metal cation salt solution to enable the upper-layer hydrogel to be fully crosslinked, thereby obtaining the crosslinked hydrogel with a double-layer structure. The double-layer hydrogel for wound repair and infection monitoring, prepared by the invention, has good adhesion, tensile property, antibacterial property and hemostatic property.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Photo-curing hydrogel capable of being combined with cytokines and used for culturing tumor organoids and application of photo-curing hydrogel

The invention discloses photocuring hydrogel capable of being combined with cytokines and used for tumor organoid culture and application, and belongs to the technical field of organoid culture. According to the invention, the hydrogel which can fix cells, can be combined with cell factors and can realize organoid recovery is developed through norbornene modified heparin, norbornene modified gelatin, sulfydryl four-arm polyethylene glycol, glucan, matrix metal protein peptidomimetic MMP and a photoinitiator. The hydrogel can be used for directly preparing organoids, heparin of various structures can be used, the cost is reduced, the modified heparin can bind factors or matrix protein and can controllably release the factors, the modified gelatin provides amino acid energy for collagen hydrolysate, and the hydrogel is formed by photocuring in a stepwise polymerization mode, is controllable in structure and can be used for preparing collagen collagen. The adjustable bionic modulus and the adjustable bionic stress relaxation are realized. The hydrogel disclosed by the invention can be used for culturing various organs, overcomes the problems of low repeatability, instability and the like in the prior art, and is suitable for the fields of tumor drug evaluation and the like.
Owner:SUZHOU XIANJUE BIOTECHNOLOGY CO LTD

Self-healing injectable photo-crosslinking dual-network hydrogel and preparation method thereof

The invention discloses a self-healing injectable photo-crosslinking dual-network hydrogel and a preparation method thereof.The preparation method comprises the steps that silk fibroin is subjected to methacrylation modification through a glycidyl methacrylate solution, then dextran of the silk fibroin is subjected to an oxidation reaction through a sodium periodate solution, oxidized dextran is generated, and the self-healing injectable photo-crosslinking dual-network hydrogel is obtained; the amino group in the modified silk fibroin and the aldehyde group of the oxidized dextran are subjected to a Schiff base cross-linking reaction to form the double-network hydrogel. The hydrogel with the double-network structure prepared by the invention is more compact in structure, so that the hydrogel has a series of excellent performances such as injectability, relatively good adhesion, good mechanical property, self-healing property and slow release property after drug loading while having safety.
Owner:HAINAN UNIV

Application of bifidobacterium animalis subsp. Lactis BX-245 in relieving inflammatory bowel disease

The application of the animal bifidobacterium subsp. Lactis BX-245 in relieving the inflammatory bowel disease is characterized in that the animal bifidobacterium subsp. Lactis BX-245 is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC No.26973. The invention also discloses an application of the animal bifidobacterium subsp. Lactis BX-245 in relieving the inflammatory bowel disease. The research aims at discussing the relieving effect of the animal bifidobacterium subsp. Lactis BX-245 on IBD mice induced by dextran sodium sulfate (DSS), and 6-week male C57BL / 6J mice which normally eat and drink water are randomly divided into a normal group (NC group), a model group (IBD group), a common yoghourt (FM group), an animal bifidobacterium subsp. Lactis BX-245 bacterial powder group (BX-245 group) and BX-245 yoghourt (BFM group). The relieving effect of the animal bifidobacterium subsp. Lactis BX-245 and the fermented milk of the animal bifidobacterium subsp. Lactis BX-245 on the symptom of the mouse inflammatory bowel disease is evaluated through weight change, immune factors, targeted metabonomics and metagenomics, and data support is provided for application of the animal bifidobacterium subsp. Lactis BX-245 in products.
Owner:GUANGZHOU FENGXING MILK CO LTD +1

Method for detecting residual quantity of dextran sulfate sodium in antibody

The invention discloses a method for detecting the residual quantity of dextran sulfate sodium in an antibody. Specifically, the invention provides a method for detecting the residual quantity of dextran sulfate sodium in an antibody, which comprises the following steps: removing protein in the antibody, and reacting with a 2-aminopyridine solution; a high performance liquid chromatography method is adopted to detect a test sample and sodium dextran sulfate standard substances with different concentrations. The detection method disclosed by the invention is low in detection limit, high in accuracy and suitable for analyzing the residual quantity of dextran sulfate in the antibody.
Owner:NANJING CHIA TAI TIANQING PHARMA

Fatty acid reaction products of dextrins or dextran formulated with a surfactant

Compositions comprising a neutral surfactant or a reaction product thereof and a reaction product of a saccharide polymer and a fatty acid may be obtained in the presence of water and a hydroxide base (optionally in the presence of the neutral surfactant), the saccharide polymer comprising a dextran, a dextrin compound, or any combination thereof. The reaction product of the saccharide polymer and the fatty acid may be present at a concentration effective to lower surface tension of the neutral surfactant. Depending on the fatty acid identity, among other factors, the compositions may promote emulsification or de-emulsification. In addition, the compositions may promote foam formation under appropriate conditions. Treatment fluids comprising the compositions, including foamed treatment fluids, may be introduced into a subterranean formation to perform a treatment operation in which fluid emulsification or de-emulsification may occur. The reaction products may be incorporated in soaps and other personal care products.
Owner:INTEGRITY BIO CHEMICALS LLC

Phytobacterium plantarum JNL0074, application thereof and microbial agent

InactiveCN119120262AContinuous secretionRegulating the immune microenvironmentBacteriaAntipyreticBiotechnologyInflammatory factors
The invention discloses a plant lactobacillus JNL0074 strain, application thereof and a microbial agent, and belongs to the technical field of microorganisms. The lactobacillus plantarum JNL0074 is preserved in the China General Microbiological Culture Collection Center on June 24, 2024, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation number is CGMCC NO: 31047, and the lactobacillus plantarum is classified and named as lactobacillus plantarum. The strain can realize high yield of indole-3-lactic acid in an MRS culture medium. An in-vitro experiment result shows that supernate of the strain remarkably inhibits inflammatory polarization of macrophages stimulated by lipopolysaccharide and secretion of inflammatory factors. Animal experiment results show that the strain can significantly inhibit sodium dextran sulfate induced colonic tissue inflammatory factor secretion and intestinal barrier injury, alleviate ulcerative colitis, and show a huge application value.
Owner:JINAN MICROECOLOGY & BIOMEDICINE PROVINCIAL LAB

Injectable hydrogel for rapid hemostasis and antibiosis of oral cavity as well as preparation method and application of injectable hydrogel

InactiveCN119679995ABandagesQuercitrinDextran
The invention relates to injectable hydrogel for rapid hemostasis and antibiosis of an oral cavity as well as a preparation method and application of the injectable hydrogel, and the injectable hydrogel comprises the following components in percentage by weight: 5-15% of aminated chondroitin sulfate, 5-15% of oxidized dextran, 1-3% of platelet-rich fibrin and 0.5-1% of quercetin modified zeolite imidazole acid framework nanoparticles. According to the invention, Chs-ADH and ODex are adopted as matrix materials, PRF and ZIF-8 (at) QCT are introduced, the hydrogel is endowed with antibacterial, anti-oxidation and immunoregulation functions, and by optimizing the proportion of the components, the obtained hydrogel has good injectability, stability and degradation resistance, so that the hydrogel can still maintain an effective blood coagulation function in a high-humidity and high-enzymatic-activity oral environment.
Owner:BEOGENE BIOTECH GUANGZHOU

Phytobacterium pentosus JNL0030, application thereof and microbial preparation

The invention discloses a strain of lactobacillus pentosus JNL0030, application thereof and a microbial preparation, and belongs to the technical field of microorganisms. The lactobacillus pentosus JNL0030 is preserved in the China General Microbiological Culture Collection Center on June 24, 2024, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation number is CGMCC (China General Microbiological Culture Collection Center) NO: 31045, and the lactobacillus pentosus is classified and named as lactobacillus pentosus. The strain can realize high yield of indole-3-lactic acid in an MRS culture medium. An in-vitro experiment result shows that supernate of the strain remarkably inhibits inflammatory polarization of macrophages stimulated by lipopolysaccharide and secretion of inflammatory factors. Animal experiment results show that the strain can significantly inhibit sodium dextran sulfate induced colonic tissue inflammatory factor secretion and intestinal barrier injury, alleviate ulcerative colitis, and show a huge application value.
Owner:JINAN MICROECOLOGY & BIOMEDICINE PROVINCIAL LAB

Bacillus dextranolyticum and application of complex microbial inoculant thereof in preparation of bio-organic fertilizer

The invention relates to the technical field of microorganisms, in particular to application of bacillus glucans and a complex microbial inoculant thereof in preparation of bio-organic fertilizers, the strain Mh85 is separated from the root system of apple rootstock Malus hupehensis treated by a research group through trichoderma TB2, has good IAA production, nitrogen fixation, inorganic phosphorus decomposition and siderophore production capacities, and can be used for preparing bio-organic fertilizers. The strain Mh85 not only can directly promote plant growth, but also has a good growth-promoting effect on trichoderma TB2, and when the strain is compounded with the trichoderma TB2 to form a complex microbial inoculant, tomato seedling pot experiments are carried out. The complex microbial inoculant shows a synergistic effect, effectively overcomes the problems of unstable growth promoting effect, insufficient synergistic effect among strains and the like of an existing single microbial preparation, provides an efficient and stable technical scheme for improving plant growth, improving root development and increasing crop yield, and is a good raw material for preparing a bio-organic fertilizer.
Owner:SANYA INSTITUTE OF NANJING AGRICULTURAL UNIVERSITY

Skin cleansing formulation

A skin cleansing formulation is provided, comprising: a dermatologically acceptable vehicle; a dermatologically acceptable oil; and a deposition aid polymer, wherein the deposition aid polymer is a cationic dextran polymer, comprising a dextran polymer functionalized with quaternary ammonium groups; wherein the deposition aid polymer enhances the deposition of the dermatologically acceptable oil from the skin cleansing formulation onto mammalian skin.
Owner:DOW GLOBAL TECHNOLOGIES LLC +1

CRISPR / Cas12a freeze-dried microsphere, three-microsphere detection system, application and kit

The invention belongs to the field of biology, and discloses a CRISPR / Cas12a freeze-dried microsphere, which is characterized in that the CRISPR / Cas12a freeze-dried microsphere is obtained by freeze-drying the following raw materials: enzyme-free water, 10 * HOLMES Buffer for Cas12a, an RNA enzyme inhibitor, CRISPR / Cas12a protein, crRNA, an upstream primer F, a downstream primer R, a fluorescent probe Reporter and a freeze-drying protective additive; the CRISPR / Cas12a protein is an LbaCas12a protein, and the CRISPR / Cas12a protein is a Cas12a protein; the freeze-drying protective agent is prepared from mannitol, trehalose, polyethylene glycol, glucan and BSA (Bovine Serum Albumin). By further optimizing a freeze-drying protective agent, freeze-drying microballing of a CRISPR / Cas12a system is achieved, the freeze-drying microballing can be matched with RPA constant-temperature amplification double microballing, and detection is conducted through a one-step method. Meanwhile, the invention further discloses a three-microsphere detection system, application and a kit.
Owner:SOUTH CHINA UNIV OF TECH

Medicine for repairing skin wound and preparation method thereof

The invention relates to a medicine for repairing skin wounds and a preparation method thereof, and belongs to the technical field of biological medicines.The medicine is prepared from, by mass, 25-30 parts of bee embryo peptide, 8-10 parts of alkannin derivative, 10-15 parts of armillaria mellea polysaccharide, 8-10 parts of inonotus obliquus polysaccharide, 6-8 parts of notoginsenoside and 5-7 parts of astragaloside. The bee fetus peptide is a product which is more than 500Da and is obtained by performing step-by-step enzymolysis on bee larva freeze-dried powder through trypsin and bacillus subtilis neutral protease to obtain enzymatic hydrolysate which is less than 3kDa, performing purification through a G-50 sephadex column, performing ultrafiltration and performing freeze-drying. The alkannin derivative is obtained by reacting alkannin with succinic anhydride and glucosamine-polyethylene glycol. A special method is adopted for preparing the bee embryo peptide and alkannin derivatives, the bee embryo peptide and alkannin derivatives are matched with other components to play a synergistic role, and the effects of high safety, high skin cell proliferation promoting capacity, excellent antibacterial performance and the like are achieved.
Owner:HUBEI SHUANGXING PHARMA CO LTD

Inflammatory bowel disease model, construction method and application thereof, and drug evaluation method based on inflammatory bowel disease model

The invention discloses an inflammatory bowel disease model, a construction method and application thereof and a drug evaluation method based on the inflammatory bowel disease model, and belongs to the technical field of inflammatory bowel disease model construction. A highly bionic intestinal crypt-villus three-dimensional structure is formed based on self-organization of an intestinal cell line C2BBe1, the intestinal crypt-villus three-dimensional structure and a DMEM complete medium containing dextran sulfate sodium are added into an upper chamber of a double-layer culture chamber Transwell, the DMEM complete medium is added into a lower chamber of the double-layer culture chamber Transwell, culture is performed for 2 days, and the inflammatory bowel disease model is obtained. The method takes effect quickly and is highly simulated, the obtained model can simulate the space-time dynamic development process of intestinal inflammation molecular characteristics, and the natural recovery model and the drug treatment model constructed based on the model can provide a brand new platform for researching an inflammation regression mechanism and a drug intervention effect.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Immune carrier microsphere constructed by individualized MHC-II combined polypeptide, vaccine and application of immune carrier microsphere and vaccine

The invention relates to the technical field of immune carrier microspheres, in particular to an immune carrier microsphere constructed by individualized MHC-II combined polypeptide, a vaccine and application of the immune carrier microsphere and the vaccine. A core comprises microspheres constructed by a plurality of MHC-II binding polypeptides, sequences of the MHC-II binding polypeptides are obtained based on HLA gene typing results of an inoculator, and each HLA gene corresponds to at least one high-affinity MHC-II binding polypeptide; a shell is a glucan with sulfydryl or other polymer coating layer, and sulfydryl is used as a coupling group to be connected with an antigen to construct the vaccine. The method has the advantages that competition is avoided, inhibition is generated, a better immune effect is achieved, antibodies of high-titer carrier molecules are not generated, and cross reaction side effects are avoided. The carrier molecular diversity is reduced; side effects are avoided. And antibody immunity and cellular immunity functions are generated. The particle size of the microspheres is controllable, and the immunologic function can be achieved without adjuvants. The preparation process is simple to operate and good in repeatability.
Owner:SHANGHAI WEIQIU BIOTECH

Preparation method of CS-Pr / Odex / EGCG composite hydrogel and product

The invention belongs to the technical field of hydrogel preparation, and particularly discloses a preparation method of CS-Pr / Odex / EGCG composite hydrogel, the hydrogel is prepared by compounding proline modified chitosan CS-Pr, oxidized dextran and EGCG, so that the prepared hydrogel not only has good injectable performance, wound healing performance and biocompatibility, but also has good biocompatibility, and can be used for preparing the hydrogel. And excellent anti-oxidation and anti-bacterial capabilities are also realized.
Owner:XINYANG NORMAL UNIVERSITY

Lactobacillus delbrueckii JNL0010, application thereof and microbial agent

The invention discloses lactobacillus delbrueckii JNL0010, application of the lactobacillus delbrueckii JNL0010 and a microbial agent, and belongs to the technical field of microorganisms. The lactobacillus delbrueckii JNL0010 is preserved in the China General Microbiological Culture Collection Center on June 24, 2024, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation number is CGMCC NO: 31042, and the lactobacillus delbrueckii JNL0010 is classified and named as lactobacillus delbrueckii subsp.bulgaricus. The lactobacillus delbrueckii JNL0010 is named as lactobacillus delbrueckii subsp.bulgaricus. The strain can realize high yield of indole-3-lactic acid in an MRS culture medium. An in-vitro experiment result shows that supernate of the strain remarkably inhibits inflammatory polarization of macrophages stimulated by lipopolysaccharide and secretion of inflammatory factors. Animal experiment results show that the strain can significantly inhibit sodium dextran sulfate induced colonic tissue inflammatory factor secretion and intestinal barrier injury, alleviate ulcerative colitis, and show a huge application value.
Owner:JINAN MICROECOLOGY & BIOMEDICINE PROVINCIAL LAB

Yak-derived Lactobacillus reuteri with anti-oxidation, anti-inflammatory and anti-hypoxia capabilities and application of Lactobacillus reuteri

The invention discloses lactobacillus reuteri with antioxidant, anti-inflammatory and anti-hypoxia capabilities, the name of the lactobacillus reuteri is QM11, the classification name of the lactobacillus reuteri is CGMCC NO.31541, the preservation number of the lactobacillus reuteri is CGMCC NO.31541, the preservation date of the lactobacillus reuteri is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing on August 5, 2024, and the preservation number of the lactobacillus reuteri is CGMCC NO.31541, the preservation number of the lactobacillus reuteri is CGMCC NO.31541, the preservation number of the lactobacillus reuteri is CGMCC NO.31541, and the preservation number of the lactobacillus reuteri is CGMCC NO.31541. The preservation unit is China General Microbiological Culture Collection Center (CGMCC). The lactobacillus reuteri is separated from faeces of healthy yaks in Qinghai province, has relatively strong acid and cholate tolerance, has relatively good antioxidant and anti-inflammatory capacities, and has a relatively strong inhibition effect on pathogenic bacteria such as yak-derived pathogenic escherichia coli, staphylococcus aureus and salmonella typhimurium; the sodium dextran sulfate induced mouse colitis symptom is relieved, and the hypoxia tolerance of the mouse is improved. The lactobacillus reuteri disclosed by the invention can be used for preparing medicines or microecological preparations for resisting oxidation, inflammation and hypoxia, and has a very wide application prospect.
Owner:TIANJIN UNIV OF SCI & TECH +1

Self-crosslinking hydrogel with tertiary amine group as well as preparation and application of self-crosslinking hydrogel

The invention discloses a self-crosslinking hydrogel with a tertiary amine group and preparation and application thereof, and belongs to the field of biomedical polymer materials, the self-crosslinking hydrogel comprises aminophenylboronic acid modified oxidized glucan, tertiary amine compound modified oxidized glucan and a solvent medium; the preparation method comprises the following steps: dissolving amino phenylboronic acid modified oxidized dextran and tertiary amine compound modified oxidized dextran in a solvent medium, mixing, standing for a certain time, and carrying out self-crosslinking to obtain the self-crosslinking hydrogel with tertiary amine groups. A cross-linking point (phenylboronic acid) of the gel network is a response unit of glucose. In addition, the hydrogel can effectively avoid uncontrollable drug release caused by non-responsive factors, and the response release efficiency of the drug is improved; by loading the hypoglycemic drug insulin to be applied to the treatment research process of diabetes, the occurrence of hypoglycemia can be avoided, and meanwhile, the possibility is provided for realizing intelligent controlled release of insulin through blood glucose response.
Owner:HANGZHOU NORMAL UNIVERSITY

Hydrogel capable of regulating and controlling redox steady state of microenvironment as well as preparation method and application of hydrogel

The invention belongs to the field of compositions of biomedical materials and high-molecular compounds, and provides hydrogel capable of regulating and controlling the redox steady state of a microenvironment as well as a preparation method and application of the hydrogel. A macromolecular network of the hydrogel capable of regulating and controlling the redox steady state of the microenvironment is formed by catechol modified hyaluronic acid, carboxylated chitosan, oxidized dextran and iron ions through a hybridization cross-linking reaction; under physiological conditions, catechol groups in the hydrogel can be subjected to an autoxidation reaction to generate H2O2, and meanwhile, iron ions coordinated on the catechol groups in the hydrogel can catalytically decompose H2O2 into water and oxygen, so that the level of active oxygen in a microenvironment is adjusted. The hydrogel disclosed by the invention can realize bidirectional regulation and control on active oxygen in a pathological microenvironment after myocardial infarction, so that the redox steady state of the pathological microenvironment after myocardial infarction is maintained, and the regeneration and repair capacity of an existing hydrogel material with antioxidant capacity on myocardial tissues after myocardial infarction is improved.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Brawler's bacteria EMF75-02B1B and application thereof

The invention relates to the technical field of microbial medicines, and particularly discloses Brawler's bacteria EMF75-02B1B and an application of the Brawler's bacteria EMF75-02B1B. The invention discloses Blauria sp. EMF75-02B1B, which is preserved in the Guangdong Microbial Culture Collection Center on September 2, 2024, and the preservation number of the Blauria sp. EMF75-02B1B is GDMCC No: 65084. A mouse model proves that the Brawler bacteria EMF75-02B1B can obviously improve the disease activity index (DAI) of a dextran sodium sulfate induced ulcerative colitis mouse, relieve the weight loss and colon shortening degree of the ulcerative colitis mouse, enhance the intestinal barrier function and relieve inflammatory response.
Owner:FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV

Hydrogel capable of regulating stem cell differentiation as well as preparation method and application of hydrogel

The invention relates to hydrogel capable of regulating stem cell differentiation as well as a preparation method and application thereof, and belongs to the technical field of biological tissue medical engineering. According to the preparation method disclosed by the invention, the dECM-ODex hydrogel of which the rigidity and viscoelasticity can be independently adjusted is synthesized by utilizing an acellular matrix (dECM) and oxidized dextran (ODex). The dECM contains a large amount of collagen, the collagen forms a main gel network skeleton during polymerization, a weak Schiff base reaction exists between the dECM and ODex, and the mechanical properties, including viscoelasticity and rigidity, of the dECM-ODex hydrogel can be adjusted by keeping the concentration of the dECM hydrogel and adjusting the number of aldehyde groups (namely the molar ratio of NaIO4 to Dex and the concentration of ODex) of the ODex at the same time. And a liver tissue mechanical environment is simulated. The synthesized dECM-ODex hydrogel can be used for regulating and controlling the differentiation of stem cells and treating liver diseases. The invention provides a new tissue engineering material selection for the treatment of liver diseases.
Owner:SUN YAT SEN UNIV +1

Antibacterial sorghum starch-based film and preparation method thereof

The preparation method comprises the following steps: (1) dissolving sorghum starch, adjusting the pH value, adding dextran branching enzyme, performing enzyme deactivation, adding pullulanase, performing debranching, performing enzyme deactivation, and gelatinizing the debranched sorghum starch; and (2) adding glycerol, malic acid and pepper essential oil into the gelatinized sorghum starch in the step (1), mixing, and freeze-drying to obtain the sorghum starch-based film. The sorghum starch-based film is endowed with antibacterial activity by adding the natural essential oil, and meanwhile, the elongation at break of the sorghum starch-based film is improved through enzymolysis.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Double-layer composite high-breathability low-sensitivity adhesive tape and preparation method thereof

The invention relates to the technical field of breathable adhesive tapes, in particular to a double-layer composite high-breathability low-sensitivity adhesive tape and a preparation method thereof. The adhesive tape comprises a hydrophobic surface layer material, a high-breathability low-sensitivity composite adhesive and release paper. The high-breathability and low-sensitivity adhesive tape comprises a three-dimensional net-shaped breathable layer and a low-sensitivity adhesive layer. The hydrophobic surface layer material adopts a polyvinylidene fluoride electrostatic spinning nanofiber membrane with high specific surface area and porosity, so that the hydrophobicity and the adhesion with the lower layer material are improved; according to the high-breathability and low-sensitivity adhesive tape, polycaprolactone, a polylactic acid-glycolic acid copolymer and polyurethane are copolymerized to obtain a multifunctional three-dimensional net-shaped breathable layer; the high-breathability and low-sensitivity composite adhesive tape is prepared from dopamine modified polydimethylsiloxane microfibers decorated by oxidized dextran modified vinyl siloxane tip fibers, and the adhesive force and biocompatibility of the adhesive tape and skins with different roughness degrees are enhanced. Meanwhile, the lignosulfonate surfactant is added, so that the reproduction of bacteria and fungi in an adhesive tape attachment area can be inhibited.
Owner:NANJING 3H MEDICAL PROD CO LTD

Genetically engineered strain for reducing formation of by-products

PendingCN119101641ABacteriaGenetically modified cellsPhosphorylethanolamineGlucan biosynthesis
The present disclosure relates to the production of oligosaccharides, in particular human milk oligosaccharides (HMO), using genetically engineered cells of phosphoglycerotransferases I and II and / or phosphoethanolamine transferases and / or dextran biosynthetic protein C with reduced or completely lost function to reduce oligosaccharide byproducts and / or increase oligosaccharide yield.
Owner:DSM IP ASSETS BV

Efficient anti-dandruff shampoo and preparation method thereof

The invention relates to efficient anti-dandruff shampoo and a preparation method thereof, and belongs to the technical field of shampoo. The efficient anti-dandruff shampoo comprises the following raw materials: 0.7%-1% of a plant extract, 0.04% of asiatic acid, 30%-35% of a humectant, 7%-10% of a surfactant, 18% of sodium propionate, 2%-4% of a thickener, 0.2%-0.3% of an emulsifier, 0.8%-1% of an acidity regulator, 0.05% of tremella polysaccharide, 2%-3% of dextran enzyme, 0.3%-0.5% of a preservative, 2%-3% of a conditioner, 0.5% of isethionate and the balance of deionized water. Three effective components including lophatherum gracile ketone, cacumen biotae extract and cnidium monnieri extract are prepared into microcapsules to be added into the shampoo, the microcapsules are mixed with asiatic acid and an anti-dandruff component isethionate, and through the combined action of all the components, the purpose of effectively removing dandruff is achieved.
Owner:SHANGHAI LIHENG ORAL BIOTECHNOLOGY DEV CO LTD